Effects of an anti-IGF-1 receptor monoclonal antibody on laminitis induced by prolonged hyperinsulinaemia in Standardbred horses
Currently, there are no registered veterinary drugs for the treatment of endocrinopathic equine laminitis, and although this form of the disease is known to be caused by prolonged hyperinsulinaemia, the mechanism of insulin toxicity is unclear. One possibility is that high concentrations of insulin...
Gespeichert in:
| Veröffentlicht in: | PloS one 2020-09, Vol.15 (9), p.e0239261-e0239261 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | e0239261 |
|---|---|
| container_issue | 9 |
| container_start_page | e0239261 |
| container_title | PloS one |
| container_volume | 15 |
| creator | Rahnama, Samira Vathsangam, Niveditha Spence, Robert Medina-Torres, Carlos E Pollitt, Christopher C de Laat, Melody A Bailey, Simon R Sillence, Martin N |
| description | Currently, there are no registered veterinary drugs for the treatment of endocrinopathic equine laminitis, and although this form of the disease is known to be caused by prolonged hyperinsulinaemia, the mechanism of insulin toxicity is unclear. One possibility is that high concentrations of insulin activate IGF-1 receptors (IGF-1R) in lamellar tissue, leading to uncontrolled cell proliferation and epidermal lamellar dysregulation. An equinized version of a human anti-IGF-1R therapeutic monoclonal antibody (mAb11) was generated to test this theory, using a modification of the prolonged euglycaemic-hyperinsulinaemic clamp technique. Healthy Standardbred horses were infused for 48 h with 0.9% saline (negative-control, n = 6), a combination of insulin (4.5 mIU/kgBW/min) and a variable infusion of 50% glucose to maintain euglycaemia (positive-control, n = 6), or insulin and glucose, preceded by a low dose of mAb11 (20 mg), designed to treat one foot only and delivered by retrograde infusion into one forelimb (mAb-treated, n = 7). Maximum insulin concentrations were 502 ± 54.4 and 435 ± 30.4 [mu]IU/mL in the positive-control and mAb11-treated groups, respectively (P = 0.33). While the control group remained healthy, all the insulin-treated horses developed laminitis within 30 h, as judged by clinical examination, foot radiographs and histological analysis. Some effects of insulin were not attenuated by the antibody, however, relative to the positive-control group, horses treated with mAb11 showed less sinking of the distal phalanx (P < 0.05) and milder histological changes, with markedly less elongation at the tips of the secondary epidermal lamellae (P < 0.05). These differences were apparent in both front feet and were statistically significant when the values for both feet were combined. The results confirm that IGF-1R may have a role in insulin-induced laminitis and suggest that mAb11 warrants further research as a potential agent to prevent or treat the disease. |
| doi_str_mv | 10.1371/journal.pone.0239261 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_2447246175</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A636883577</galeid><doaj_id>oai_doaj_org_article_09050774ddb0439ebe6a4454d42bc4cd</doaj_id><sourcerecordid>A636883577</sourcerecordid><originalsourceid>FETCH-LOGICAL-c669t-20030a67aeb27506ca967b99a9051291f48f67d3a34274cb5cae2e98b5f7a2503</originalsourceid><addsrcrecordid>eNqNk99rFDEQxxdRbK3-B4ILgujDndkkm2xeCqW09aBQsOprmE2ydym7yZpkxXvzTzfXO6UrfZAE8usz38lMMkXxukLLivDq452fgoN-OXpnlggTgVn1pDiuBMELhhF5-mB-VLyI8Q6hmjSMPS-OCBaiqgU5Ln5ddJ1RKZa-K8HlnuxidXW5qMpglBmTD-XgnVe9z77uj1uvt6V3ZQ-DdTbZWFqnJ2V02W7LMfhMrvNisx1NsC5OvXVgBgsZK28TOA1Bt2FH-BBNfFk866CP5tVhPCm-Xl58Of-0uL65Wp2fXS8UYyItMEIEAeNgWsxrxBQIxlshQKC6wqLqaNMxrgkQijlVba3AYCOatu444BqRk-LNXnfsfZSH5EWJKeWYsorXmVjtCe3hTo7BDhC20oOV9xs-rCWEZFVvJMpeEedU6xZRIkxrGFBaU01xq6jSWev04G1qB6OVcSlAPxOdnzi7kWv_Q_Ia0xxqFnh_EAj--2RikoONyvQ9OOOn_b1r2iBWZfTtP-jj0R2oNeQArOt89qt2ovKMEdY0pOY8U8tHqNx0fkKVf1pn8_7M4MPMIDPJ_ExrmGKUq9vP_8_efJuz7x6wGwN92kTfT8l6F-cg3YMq-BiD6f4muUJyVyh_siF3hSIPhUJ-A7sUBMk</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2447246175</pqid></control><display><type>article</type><title>Effects of an anti-IGF-1 receptor monoclonal antibody on laminitis induced by prolonged hyperinsulinaemia in Standardbred horses</title><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><source>Public Library of Science (PLoS)</source><creator>Rahnama, Samira ; Vathsangam, Niveditha ; Spence, Robert ; Medina-Torres, Carlos E ; Pollitt, Christopher C ; de Laat, Melody A ; Bailey, Simon R ; Sillence, Martin N</creator><creatorcontrib>Rahnama, Samira ; Vathsangam, Niveditha ; Spence, Robert ; Medina-Torres, Carlos E ; Pollitt, Christopher C ; de Laat, Melody A ; Bailey, Simon R ; Sillence, Martin N</creatorcontrib><description>Currently, there are no registered veterinary drugs for the treatment of endocrinopathic equine laminitis, and although this form of the disease is known to be caused by prolonged hyperinsulinaemia, the mechanism of insulin toxicity is unclear. One possibility is that high concentrations of insulin activate IGF-1 receptors (IGF-1R) in lamellar tissue, leading to uncontrolled cell proliferation and epidermal lamellar dysregulation. An equinized version of a human anti-IGF-1R therapeutic monoclonal antibody (mAb11) was generated to test this theory, using a modification of the prolonged euglycaemic-hyperinsulinaemic clamp technique. Healthy Standardbred horses were infused for 48 h with 0.9% saline (negative-control, n = 6), a combination of insulin (4.5 mIU/kgBW/min) and a variable infusion of 50% glucose to maintain euglycaemia (positive-control, n = 6), or insulin and glucose, preceded by a low dose of mAb11 (20 mg), designed to treat one foot only and delivered by retrograde infusion into one forelimb (mAb-treated, n = 7). Maximum insulin concentrations were 502 ± 54.4 and 435 ± 30.4 [mu]IU/mL in the positive-control and mAb11-treated groups, respectively (P = 0.33). While the control group remained healthy, all the insulin-treated horses developed laminitis within 30 h, as judged by clinical examination, foot radiographs and histological analysis. Some effects of insulin were not attenuated by the antibody, however, relative to the positive-control group, horses treated with mAb11 showed less sinking of the distal phalanx (P < 0.05) and milder histological changes, with markedly less elongation at the tips of the secondary epidermal lamellae (P < 0.05). These differences were apparent in both front feet and were statistically significant when the values for both feet were combined. The results confirm that IGF-1R may have a role in insulin-induced laminitis and suggest that mAb11 warrants further research as a potential agent to prevent or treat the disease.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0239261</identifier><identifier>PMID: 32991593</identifier><language>eng</language><publisher>San Francisco: Public Library of Science</publisher><subject>Antibodies ; Biology ; Biology and Life Sciences ; Cell growth ; Cell proliferation ; Drug therapy ; Elongation ; Environmental science ; Feet ; Finger ; Gene expression ; Glucose ; Health aspects ; Horses ; Hypotheses ; Insulin ; Insulin-like growth factor I ; Laboratories ; Lamellae ; Laminitis ; Medicine and Health Sciences ; Monoclonal antibodies ; People and Places ; Physical Sciences ; Physiology ; Radiographs ; Radiography ; Receptors ; Statistical analysis ; Toxicity ; Veterinary medicine</subject><ispartof>PloS one, 2020-09, Vol.15 (9), p.e0239261-e0239261</ispartof><rights>COPYRIGHT 2020 Public Library of Science</rights><rights>2020 Rahnama et al. This is an open access article distributed under the terms of the Creative Commons Attribution License: http://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2020 Rahnama et al 2020 Rahnama et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c669t-20030a67aeb27506ca967b99a9051291f48f67d3a34274cb5cae2e98b5f7a2503</citedby><cites>FETCH-LOGICAL-c669t-20030a67aeb27506ca967b99a9051291f48f67d3a34274cb5cae2e98b5f7a2503</cites><orcidid>0000-0001-9348-5497 ; 0000-0003-2837-5456 ; 0000-0001-5731-6602 ; 0000-0001-7082-7386</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524003/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7524003/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,2096,2915,23845,27901,27902,53766,53768,79342,79343</link.rule.ids></links><search><creatorcontrib>Rahnama, Samira</creatorcontrib><creatorcontrib>Vathsangam, Niveditha</creatorcontrib><creatorcontrib>Spence, Robert</creatorcontrib><creatorcontrib>Medina-Torres, Carlos E</creatorcontrib><creatorcontrib>Pollitt, Christopher C</creatorcontrib><creatorcontrib>de Laat, Melody A</creatorcontrib><creatorcontrib>Bailey, Simon R</creatorcontrib><creatorcontrib>Sillence, Martin N</creatorcontrib><title>Effects of an anti-IGF-1 receptor monoclonal antibody on laminitis induced by prolonged hyperinsulinaemia in Standardbred horses</title><title>PloS one</title><description>Currently, there are no registered veterinary drugs for the treatment of endocrinopathic equine laminitis, and although this form of the disease is known to be caused by prolonged hyperinsulinaemia, the mechanism of insulin toxicity is unclear. One possibility is that high concentrations of insulin activate IGF-1 receptors (IGF-1R) in lamellar tissue, leading to uncontrolled cell proliferation and epidermal lamellar dysregulation. An equinized version of a human anti-IGF-1R therapeutic monoclonal antibody (mAb11) was generated to test this theory, using a modification of the prolonged euglycaemic-hyperinsulinaemic clamp technique. Healthy Standardbred horses were infused for 48 h with 0.9% saline (negative-control, n = 6), a combination of insulin (4.5 mIU/kgBW/min) and a variable infusion of 50% glucose to maintain euglycaemia (positive-control, n = 6), or insulin and glucose, preceded by a low dose of mAb11 (20 mg), designed to treat one foot only and delivered by retrograde infusion into one forelimb (mAb-treated, n = 7). Maximum insulin concentrations were 502 ± 54.4 and 435 ± 30.4 [mu]IU/mL in the positive-control and mAb11-treated groups, respectively (P = 0.33). While the control group remained healthy, all the insulin-treated horses developed laminitis within 30 h, as judged by clinical examination, foot radiographs and histological analysis. Some effects of insulin were not attenuated by the antibody, however, relative to the positive-control group, horses treated with mAb11 showed less sinking of the distal phalanx (P < 0.05) and milder histological changes, with markedly less elongation at the tips of the secondary epidermal lamellae (P < 0.05). These differences were apparent in both front feet and were statistically significant when the values for both feet were combined. The results confirm that IGF-1R may have a role in insulin-induced laminitis and suggest that mAb11 warrants further research as a potential agent to prevent or treat the disease.</description><subject>Antibodies</subject><subject>Biology</subject><subject>Biology and Life Sciences</subject><subject>Cell growth</subject><subject>Cell proliferation</subject><subject>Drug therapy</subject><subject>Elongation</subject><subject>Environmental science</subject><subject>Feet</subject><subject>Finger</subject><subject>Gene expression</subject><subject>Glucose</subject><subject>Health aspects</subject><subject>Horses</subject><subject>Hypotheses</subject><subject>Insulin</subject><subject>Insulin-like growth factor I</subject><subject>Laboratories</subject><subject>Lamellae</subject><subject>Laminitis</subject><subject>Medicine and Health Sciences</subject><subject>Monoclonal antibodies</subject><subject>People and Places</subject><subject>Physical Sciences</subject><subject>Physiology</subject><subject>Radiographs</subject><subject>Radiography</subject><subject>Receptors</subject><subject>Statistical analysis</subject><subject>Toxicity</subject><subject>Veterinary medicine</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><sourceid>DOA</sourceid><recordid>eNqNk99rFDEQxxdRbK3-B4ILgujDndkkm2xeCqW09aBQsOprmE2ydym7yZpkxXvzTzfXO6UrfZAE8usz38lMMkXxukLLivDq452fgoN-OXpnlggTgVn1pDiuBMELhhF5-mB-VLyI8Q6hmjSMPS-OCBaiqgU5Ln5ddJ1RKZa-K8HlnuxidXW5qMpglBmTD-XgnVe9z77uj1uvt6V3ZQ-DdTbZWFqnJ2V02W7LMfhMrvNisx1NsC5OvXVgBgsZK28TOA1Bt2FH-BBNfFk866CP5tVhPCm-Xl58Of-0uL65Wp2fXS8UYyItMEIEAeNgWsxrxBQIxlshQKC6wqLqaNMxrgkQijlVba3AYCOatu444BqRk-LNXnfsfZSH5EWJKeWYsorXmVjtCe3hTo7BDhC20oOV9xs-rCWEZFVvJMpeEedU6xZRIkxrGFBaU01xq6jSWev04G1qB6OVcSlAPxOdnzi7kWv_Q_Ia0xxqFnh_EAj--2RikoONyvQ9OOOn_b1r2iBWZfTtP-jj0R2oNeQArOt89qt2ovKMEdY0pOY8U8tHqNx0fkKVf1pn8_7M4MPMIDPJ_ExrmGKUq9vP_8_efJuz7x6wGwN92kTfT8l6F-cg3YMq-BiD6f4muUJyVyh_siF3hSIPhUJ-A7sUBMk</recordid><startdate>20200929</startdate><enddate>20200929</enddate><creator>Rahnama, Samira</creator><creator>Vathsangam, Niveditha</creator><creator>Spence, Robert</creator><creator>Medina-Torres, Carlos E</creator><creator>Pollitt, Christopher C</creator><creator>de Laat, Melody A</creator><creator>Bailey, Simon R</creator><creator>Sillence, Martin N</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-9348-5497</orcidid><orcidid>https://orcid.org/0000-0003-2837-5456</orcidid><orcidid>https://orcid.org/0000-0001-5731-6602</orcidid><orcidid>https://orcid.org/0000-0001-7082-7386</orcidid></search><sort><creationdate>20200929</creationdate><title>Effects of an anti-IGF-1 receptor monoclonal antibody on laminitis induced by prolonged hyperinsulinaemia in Standardbred horses</title><author>Rahnama, Samira ; Vathsangam, Niveditha ; Spence, Robert ; Medina-Torres, Carlos E ; Pollitt, Christopher C ; de Laat, Melody A ; Bailey, Simon R ; Sillence, Martin N</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c669t-20030a67aeb27506ca967b99a9051291f48f67d3a34274cb5cae2e98b5f7a2503</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antibodies</topic><topic>Biology</topic><topic>Biology and Life Sciences</topic><topic>Cell growth</topic><topic>Cell proliferation</topic><topic>Drug therapy</topic><topic>Elongation</topic><topic>Environmental science</topic><topic>Feet</topic><topic>Finger</topic><topic>Gene expression</topic><topic>Glucose</topic><topic>Health aspects</topic><topic>Horses</topic><topic>Hypotheses</topic><topic>Insulin</topic><topic>Insulin-like growth factor I</topic><topic>Laboratories</topic><topic>Lamellae</topic><topic>Laminitis</topic><topic>Medicine and Health Sciences</topic><topic>Monoclonal antibodies</topic><topic>People and Places</topic><topic>Physical Sciences</topic><topic>Physiology</topic><topic>Radiographs</topic><topic>Radiography</topic><topic>Receptors</topic><topic>Statistical analysis</topic><topic>Toxicity</topic><topic>Veterinary medicine</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rahnama, Samira</creatorcontrib><creatorcontrib>Vathsangam, Niveditha</creatorcontrib><creatorcontrib>Spence, Robert</creatorcontrib><creatorcontrib>Medina-Torres, Carlos E</creatorcontrib><creatorcontrib>Pollitt, Christopher C</creatorcontrib><creatorcontrib>de Laat, Melody A</creatorcontrib><creatorcontrib>Bailey, Simon R</creatorcontrib><creatorcontrib>Sillence, Martin N</creatorcontrib><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection (ProQuest)</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rahnama, Samira</au><au>Vathsangam, Niveditha</au><au>Spence, Robert</au><au>Medina-Torres, Carlos E</au><au>Pollitt, Christopher C</au><au>de Laat, Melody A</au><au>Bailey, Simon R</au><au>Sillence, Martin N</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of an anti-IGF-1 receptor monoclonal antibody on laminitis induced by prolonged hyperinsulinaemia in Standardbred horses</atitle><jtitle>PloS one</jtitle><date>2020-09-29</date><risdate>2020</risdate><volume>15</volume><issue>9</issue><spage>e0239261</spage><epage>e0239261</epage><pages>e0239261-e0239261</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Currently, there are no registered veterinary drugs for the treatment of endocrinopathic equine laminitis, and although this form of the disease is known to be caused by prolonged hyperinsulinaemia, the mechanism of insulin toxicity is unclear. One possibility is that high concentrations of insulin activate IGF-1 receptors (IGF-1R) in lamellar tissue, leading to uncontrolled cell proliferation and epidermal lamellar dysregulation. An equinized version of a human anti-IGF-1R therapeutic monoclonal antibody (mAb11) was generated to test this theory, using a modification of the prolonged euglycaemic-hyperinsulinaemic clamp technique. Healthy Standardbred horses were infused for 48 h with 0.9% saline (negative-control, n = 6), a combination of insulin (4.5 mIU/kgBW/min) and a variable infusion of 50% glucose to maintain euglycaemia (positive-control, n = 6), or insulin and glucose, preceded by a low dose of mAb11 (20 mg), designed to treat one foot only and delivered by retrograde infusion into one forelimb (mAb-treated, n = 7). Maximum insulin concentrations were 502 ± 54.4 and 435 ± 30.4 [mu]IU/mL in the positive-control and mAb11-treated groups, respectively (P = 0.33). While the control group remained healthy, all the insulin-treated horses developed laminitis within 30 h, as judged by clinical examination, foot radiographs and histological analysis. Some effects of insulin were not attenuated by the antibody, however, relative to the positive-control group, horses treated with mAb11 showed less sinking of the distal phalanx (P < 0.05) and milder histological changes, with markedly less elongation at the tips of the secondary epidermal lamellae (P < 0.05). These differences were apparent in both front feet and were statistically significant when the values for both feet were combined. The results confirm that IGF-1R may have a role in insulin-induced laminitis and suggest that mAb11 warrants further research as a potential agent to prevent or treat the disease.</abstract><cop>San Francisco</cop><pub>Public Library of Science</pub><pmid>32991593</pmid><doi>10.1371/journal.pone.0239261</doi><tpages>e0239261</tpages><orcidid>https://orcid.org/0000-0001-9348-5497</orcidid><orcidid>https://orcid.org/0000-0003-2837-5456</orcidid><orcidid>https://orcid.org/0000-0001-5731-6602</orcidid><orcidid>https://orcid.org/0000-0001-7082-7386</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1932-6203 |
| ispartof | PloS one, 2020-09, Vol.15 (9), p.e0239261-e0239261 |
| issn | 1932-6203 1932-6203 |
| language | eng |
| recordid | cdi_plos_journals_2447246175 |
| source | DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central; Free Full-Text Journals in Chemistry; Public Library of Science (PLoS) |
| subjects | Antibodies Biology Biology and Life Sciences Cell growth Cell proliferation Drug therapy Elongation Environmental science Feet Finger Gene expression Glucose Health aspects Horses Hypotheses Insulin Insulin-like growth factor I Laboratories Lamellae Laminitis Medicine and Health Sciences Monoclonal antibodies People and Places Physical Sciences Physiology Radiographs Radiography Receptors Statistical analysis Toxicity Veterinary medicine |
| title | Effects of an anti-IGF-1 receptor monoclonal antibody on laminitis induced by prolonged hyperinsulinaemia in Standardbred horses |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T14%3A52%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20an%20anti-IGF-1%20receptor%20monoclonal%20antibody%20on%20laminitis%20induced%20by%20prolonged%20hyperinsulinaemia%20in%20Standardbred%20horses&rft.jtitle=PloS%20one&rft.au=Rahnama,%20Samira&rft.date=2020-09-29&rft.volume=15&rft.issue=9&rft.spage=e0239261&rft.epage=e0239261&rft.pages=e0239261-e0239261&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0239261&rft_dat=%3Cgale_plos_%3EA636883577%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2447246175&rft_id=info:pmid/32991593&rft_galeid=A636883577&rft_doaj_id=oai_doaj_org_article_09050774ddb0439ebe6a4454d42bc4cd&rfr_iscdi=true |